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Abstract 
Chronic obstructive pulmonary disease (COPD) is a common, preventable and incurable disease. The 
costs of caring for patients with COPD is estimated to be more than £800 milion a year for acute 
hospital admissions alone (Department of Health, 2012). The hospital-at-home model is increasingly 
being adopted for COPD patients following British Thoracic Society (BTS) guidelines for the delivery 
of hospital admission-avoidance schemes (BTS, 2007). The aim of this case-note review was to 
evaluate the safety and effectiveness of a specialist nurse-led acute respiratory assessment service 
working with COPD patients in the community. The review recorded patient flow through the service 
and documented assessments and treatments. It was able to document potential benefits and cost 
savings. 
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Chronic obstructive pulmonary disease (COPD) is characterised by persistent and usually progressive 
airflow limitation, most commonly caused by cigarette smoking (Rabe et al, 2016 (see reference 
list)). It is a common, preventable and treatable disease that, despite the provision of 
pharmacological and non-pharmacological treatments, remains incurable. 
The cost of caring for patients with COPD is estimated to be more than £800 million a year for acute 
hospital care alone (Department of Health (DH), 2012). It is the second highest cause of emergency 
admissions of any chronic disease in the UK (DH, 2010). Hospitalisation is responsible for up to 60% 
of the total cost of management for COPD patientsGuest, 1999; O’Reilly et al, 2007), and it is 
inevitable that these costs will continue to rise owing to the increasing number of people living with 
long-term conditions (DH, 2013). For the healthcare system, acute exacerbations of COPD are the 
most common cause of hospital admission, particularly in the winter, which places heightened 
pressure on demands for hospital beds (Ram et al, 2004). It is therefore essential that alternate safe 
and effective models of care are developed in order to reduce unnecessary acute admissions and to 
provide patients and carers with the appropriate professional support and education to facilitate 
effective self-management. 
Background 
The hospital-at-home model is becoming increasingly adopted for patients with COPD following 
recommendations and guidance from the British Thoracic Society (BTS) (2007). The guidelines detail 
key recommendations for the safe and effective delivery of admission-avoidance schemes, which 
include: inclusion and exclusion criteria, key skills of health professionals working within such teams, 
and assessment and treatment options. 
The evidence for providing such a service for patients experiencing an acute exacerbation of COPD 
remains contradictory. It has been suggested that admission-avoidance schemes have no significant 
benefits when compared to inpatient hospital care (Shepperd et al, 2008). Shepperd et al (2016) 
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suggested that hospital-at-home may be an effective alternative for a small group of patients and 
may be more cost effective than acute admission to hospital. More recently, Fernandez et al (2013) 
concluded that hospital at home is a good, safe alternative, and that readmissions were associated 
with co-morbidities rather than the type and place of management for the acute episode. 
A systematic review of eight randomised controlled trials with 870 patients concluded that hospital-
at-home schemes were safe and demonstrated a significant reduction in readmission rates and a 
trend towards reduced mortality rate when compared with conventional inpatient treatment of 
acute exacerbations of COPD (Jeppesen et al, 2012). The systematic review did, however, identify a 
lack of evidence of patient satisfaction in either setting and the need for future research to 
determine which medical professionals are most appropriate to deliver hospital-at-home services. 
It has been widely demonstrated that clinical nurse specialists add extra value to patients while 
generating efficiencies for organisations through innovative ways of working (RCN, 2010). The 
holistic care and timely interventions provided by clinical nurse specialists not only help to reduce 
patient morbidity, but also potentially prevent costly care episodes such as unplanned hospital 
admissions (Baxter and Leary, 2011). The majority of studies evaluating hospital-at-home schemes 
have recruited patients who present to accident and emergency departments and may or may not 
have been admitted to hospital, and therefore are referred following assessment by a team of 
doctors and nurses in the acute setting and/or by a specialist respiratory physician. Knolle et al 
(2011) developed acommunity-based model of direct referral of patients to COPD specialist nurses 
from primary care, demonstrating it to be a safe method of reducing unnecessary hospital 
admissions. The findings of this service evaluation was promising, but further work is required to 




The aim of this review was to evaluate the safety and effectiveness of a specialist nurse-led acute 
respiratory assessment service (ARAS) for patients diagnosed with COPD to avoid unnecessary 
hospital admission. The objectives of the review were to record patient-flow through the admission 
avoidance pathway, document the treatment provided to the patients, identify potential benefits 
and cost savings of providing specialist versus generalist care and report patient satisfaction with the 
service. 
Setting 
Lincolnshire is a large rural county with a total population of 724 000, a higher than average 
percentage of smokers at 19.1% and a higher than national current COPD prevalence of 2.2% of the 
population, predicted to rise to 2.8% (Public Health England, 2015). The ARAS is commissioned to 
provide a hospital-at-home/admission avoidance service for patients with COPD, which is delivered 
by the Lincolnshire countywide community respiratory team. This service allows direct referral 
before patients are admitted to hospital. ARAS is provided to patients with a confirmed diagnosis of 
COPD who experience an acute exacerbation and require specialist care. It covers the geographic 
areas of west, east and south-east Lincolnshire, covering the boundaries of the former west, east 
and southeast Lincolnshire clinical commissioning groups. Within the west Lincolnshire area there 
are currently two whole time equivalent (WTE) band 7 respiratory nurse specialist posts 
commissioned to support the service. Each of the four nurses within the team is a non-medical 
prescriber, has respiratory specialist qualifications to a minimum of degree level and is competent in 




Patients with a confirmed diagnosis of COPD who present with an acute exacerbation of COPD and 
are deemed to require further support to prevent hospital admission are referred to the community 
respiratory nurse specialists. To be eligible for the service, COPD patients must be able to cope at 
home and have suitable social circumstances. Patients with significant co-morbidities are excluded. 
Co-morbidities include acute left ventricular failure and congestive cardiac failure, pneumonia, an 
undiagnosed chest or cardiac condition, confused or agitated patients and those with a coexistent 
lung disease (such as asthma, bronchiectasis, interstitial lung disease, lung cancer). Referrals are 
made directly to ARAS from primary and secondary care clinicians and emergency care staff. Patients 
on a current respiratory caseload are able to self-refer. The referral is triaged by a respiratory nurse 
specialist and, if deemed appropriate for the service, the patient is contacted and an appointment to 
review at home is made for the next working day.  
On initial assessment a comprehensive respiratory and holistic assessment is completed by a 
respiratory nurse specialist. This includes current and past medical history, medication review, 
including inhaler technique, physical examination, review of social circumstances and objective 
assessments including temperature, pulse rate, respiration rate, blood pressure and capillary blood 
gas (CBG) assessment if indicated. A personalised management plan is provided and discussed in 
depth with each patient and medications prescribed as indicated. These may include antibiotics, oral 
steroids, bronchodilators, nebulised treatment and oxygen therapy. Patients are reviewed at home 
and by telephone as clinically indicated, for a period of up to 14 days, although this is flexible 
dependent on the severity and level of support required. The respiratory nurse specialist can also 
refer patients directly to other services including occupational therapy, physiotherapy, social care, 





For the purpose of this review, data were analysed from the case notes of patients referred to the 
service over a 12-month period from 1 April 2014 to 31 March 2015. Data were also collected from 
anonymous surveys that patients were asked to complete to assess satisfaction on discharge from 
ARAS. Patients were asked to rate their satisfaction on a scale of 1 (not at all) to 5 (totally) to the 
following questions: 
 How likely are you to recommend our services to your friends and family if they needed 
similar care or treatment?  
 Were you treated with dignity and respect?  
 Were you involved as much as you wanted to be in your treatment and care plan?  
 Did you receive clear information about your care and treatment?  
 Were you treated with kindness and compassion by all the staff looking after you? 
Results 
During this review period 128 patients (mean ± standard deviation; age 74.2 ± 11.0 years) referred 
were appropriate for acceptance on to ARAS. Sources of referrals are given in Figure 1. 
A further 15 patients were referred but deemed inappropriate for the ARAS service: 14 patients had 
a non-COPD diagnosis and one patient was admitted to hospital before an initial assessment could 
take place.  
All patients accepted were seen on the next working day following referral and were provided with a 
personalised management plan. The mean number of patient visits and telephone reviews by the 
respiratory nurse specialist was 3.5 ± 1.4 and 1.5 ± 1.4 respectively. The total number of days on the 
scheme was 16 ± 8.8. All patients were initially treated with antibiotics and oral steroids. Ninety-two 
patients (72%) were treated with nebulised bronchodilators either with their own nebuliser or one 
provided on short-term loan from the ARAS team. Sputum culture was obtained in 26 patients (20%) 
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with 50% of these being negative, 30% positive for Haemophilus influenzae, 8% for Pseudomonas 
aeruginosa, 8% for Moraxella catarrhalis and 4% for Streptococcus pneumoniae.  
On initial assessment, pulse oximetry results showed a mean peripheral capillary oxygen saturation 
(SpO2) of 93% ± 3, with 21 (16%) patients hypoxemic and requiring further CBG assessment. Of 
those requiring CBG assessment, seven (33.3%) were already receiving long-term oxygen therapy 
(LTOT) and required adjustment of flow rate, eight patients (38.1%) were started on LTOT and three 
patients (14.3%) had a normal CBG, with a partial pressure of oxygen (PaO2) of >8kPa. A further two 
patients (9.5%) were hypoxemic but oxygen therapy was considered inappropriate. One had a 
critical risk of fire, because of a heavy smoking habit and the other had acute type 2 respiratory 
failure. The latter of these patients was admitted, along with one other from this group of patients. 
We were unable to obtain a result from one patient (4.8%) who refused hospital admission. Short-
burst oxygen was prescribed and monitored using pulse oximetry and the patient was managed 
safely at home. The admission costs for these 21 patients, if managed by generalists, would equate 
to £55 314, whereas the actual cost for this group totalled £7 899.72. This sum included admission 
costs for two patients admitted due to respiratory causes and the cost of respiratory nurse specialist 
time and initiation of emergency oxygen where indicated (Table 1). 
From the total cohort of patients only ten out of 128 referrals resulted in hospital (all-cause) 
admissions (7.8%) (Figure 2). Only six of these admissions were owing to ongoing respiratory causes 
and poor response to treatment, two of these being from the same patient who was referred to 
ARAS on two separate occasions. All patients recovered from the acute episode and therefore the 
mortality rate for all patients referred to ARAS during the treatment period was nil.  
Patient satisfaction 
Forty-eight patients completed satisfaction questionnaires. All of those questioned stated they 
would be ‘Extremely likely’ to recommend the service (in response to question 1). Questions 2 to 5 
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were scored from 1 to 5 ranging from answers ‘not at all = 1’ to ‘totally = 5’. The mean score for all 
answers was 4.93 out of 5, indicating that the patients were extremely satisfied with the service, felt 
involved in their care and agreed that they were provided with clear information. Patients also 
provided qualitative comments relating to the care and treatment received during their time with 
ARAS (Box 1).  
Discussion 
The results obtained demonstrate that the specialist skills of all respiratory nurse specialists were a 
significant contributory factor in the success of the scheme, particularly the ability to undertake and 
interpret capillary blood gas assessments and initiate emergency oxygen as indicated. Results 
demonstrate that 21 patients were hypoxemic on initial review and, without management by a 
respiratory nurse specialist, specialist hospital admission for further assessment would have been 
required in line with national guidance (National Institute for Health and Care Excellence (NICE), 
2010). This would increase admission rates in this cohort to 21.1% for respiratory reasons, as 
opposed to 4.6%. The admission cost for these patients if managed by generalists would equate to 
£76 386, whereas the actual cost for this cohort totalled £28 971.72 (Table 1). This sum includes 
admission costs for ten patients admitted and the cost of respiratory nurse specialist time and 
initiation of emergency oxygen where indicated. Generalist costs also include the admission costs of 
19 patients who would otherwise have met admission criteria if the patients had been managed by 
health professionals who did not have the skills to monitor and initiate oxygen therapy. 
Therefore the specialist team saved an estimated £47 414.28 for this cohort, when compared with 
generalist care. This may be a minimum cost saving as this assumes that all other patients within this 
cohort would have remained at home. However, due to the nature of this review, the exact cost of 
consumables used could not be calculated.  
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CBG assessment is the preferred method of assessment by the community team as opposed to 
arterial blood gas (ABG) assessment, as it has been proven that there is good correlation for 
estimating PaO2 (Eaton et al, 2001) and is a more comfortable procedure than ABGs (Pitkin et al, 
1994). 
The latest BTS guidelines recommend that patients being assessed for LTOT should undergo initial 
assessment for suitability, using ABG sampling. However, where this is not practical in a home 
environment, the guidelines state that a combination of CBGs and oximetry (but not capnography) 
could be used as an alternative (Hardinge et al, 2015). 
From the ten admissions during the period of this review, four were due to non-respiratory causes 
(Figure 2). The two admissions owing to cardiac causes were both assessed by the respiratory nurses 
and admission was arranged immediately, thus demonstrating the advanced level of assessment 
skills required by this role. Figure 2 highlights the complex conditions that patients seen by the team 
experience and demonstrates that patients are more likely to be admitted to hospital if they have 
severe comorbidities or are in current receipt of LTOT (Table 2). Similar problems were identified by 
Jeppesen et al (2012). 
Since the introduction of ARAS in 2010, hospital admission rates have reduced significantly including 
during the time period reviewed. However, it is difficult to attribute this reduction solely to the 
ARAS. Another strength of the respiratory nurse specialist led-service, underlying the continued 
reduction in admission rates, may be the self-management education given. Patients receiving the 
service are more aware of the community services available and have the confidence to access and 
self-refer back to the service as required. The appropriate use of self-management plans encourages 
patients to access treatment at an early stage at the first sign of an exacerbation (NICE, 2010). 
Wilson et al (2006), identified that, apart from specialist nurses, the majority of nurses (including 
community nurses) were limited in facilitating self-management. Therefore, the benefits for the use 
of self-management plans are greater when combined with education and support of a respiratory 
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nurse specialist who also has the ability to optimise inhaled therapies and review inhaler technique 
(Tashkin et al, 2008). 
Providing an individual and holistic assessment and referring to other services can also have a 
longer-term impact. Reinforcing the multidisciplinary approach, and incorporating this with physical 
training, disease education and psychological and behavioural interventions, can improve health-
related quality of life in COPD patients (Puhan et al, 2016). 
The findings of this review highlight the importance of increasing awareness and availability of these 
schemes. Specialist nurses have a key role to play when supporting admission avoidance and have 
the ability to care for patients safely and effectively and prescribe treatment that would otherwise 
necessitate hospital admission if managed by generalists. This therefore emphasises the importance 
of continued education and training to develop and maintain specialist roles. These findings can be 
used to support planning and delivery of hospital-at-home schemes nationally and internationally. 
Limitations 
Our study is a retrospective analysis of case notes with all the inherent limitations. Reliance on the 
accuracy and completeness of documentation should be viewed cautiously, as it was not recorded 
for the specific purpose of research. The lack of randomisation and blinding makes it difficult to 
control bias and confounders. The number of notes analysed was relatively small, but surveying 
consecutive cases helped to minimise selection bias. The audit was conducted in one centre, but 
may well reflect the practice in other centres offering an ARAS. 
The service operates on weekdays only. Work is being undertaken to align specialist nursing teams 
with community nursing teams. This will provide opportunities to educate general nurses and create 
closer links to support the ongoing education and self-management of COPD patients at all stages. It 
may be a requirement to develop a specialist nurse on-call service for weekends to support 
community nursing teams for patients with complex conditions. However, until GP surgeries open 
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routinely at weekends, there is only a minimal need for this at present as GPs are the main referrers 
for ARAS. 
The patient survey assessed satisfaction with the service but changes in the condition of patients 
pre- and post-treatment were not captured routinely. It would therefore be beneficial to introduce a 
validated assessment tool, such as the COPD Assessment Test (Jones et al, 2009) to assess these 
changes, thereby providing an opportunity to include patient-centred and individual measures to 
assess efficacy of treatment. The surveys collected were kept anonymous and therefore we were 
unable to analyse patient profiles. A more in-depth qualitative research study may be of benefit. 
Details relating to the severity of COPD and previous hospital admissions were not obtained for the 
purpose of this review. It would also be interesting to obtain hospital admissions and mortality rates 
in the 12 months following referral to ARAS. 
Gathering this information would provide increased evidence to support the future delivery of such 
services and may provide vital information to demonstrate which patients would be the most 
appropriate to receive this service in the long term. This review justifies the need for further 
research into this area, capturing these key elements to analyse safety, effectiveness and the longer-
term impact of hospital-at-home schemes. 
Conclusion 
In summary, this retrospective case-note review suggests that a community specialist nurse-led 
admission avoidance service can be a safe and cost-effective model of care for managing patients 
experiencing acute exacerbations of COPD. It is vital that all healthcare professionals involved are 
skilled and competent in assessing and prescribing appropriate pharmacological treatment, 
undertaking a CBG assessment, and that the provision of equipment is available to enable these key 
skills to be undertaken appropriately. Healthcare professionals should also have the ability to 
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provide specialist education to promote effective self-management. This model is replicable and 
would be appropriate to incorporate into all admission-avoidance schemes for COPD patients.  
 14 
Declaration of interest: none 
Acknowledgements: the authors wish to thank the library service at United Lincolnshire Hospitals 
NHS Trust for undertaking a literature review to provide appropriate evidence to support this article  
 15 
References 
Baxter J, Leary A (2011) Productivity gains by specialist nurses. Nurs Times 107: (30-31): 15-7 
British Thoracic Society (2007) Intermediate care: Hospital-at-Home in chronic obstructive 
pulmonary disease: British Thoracic Society Guideline. Thorax 62(3): 200-10. 
https://dx.doi.org/10.1136/thx.2006.064931 
Hardinge M, Annandale J, Bourne S (2015) British Thoracic Society guidelines for home oxygen use in 
adults. Thorax 70(1 suppl): 1-44. https://dx.doi.org/10.1136/thoraxjnl-2015-206865 
Department of Health (2010) Consultation on a Strategy for Services for Chronic Obstructive 
Pulmonary Disease in England. https://tinyurl.com/3lyu6ku (accessed 27 January 2017) 
Department of Health (2012) COPD Commissioning Toolkit. A Resource for Commissioners. 
https://tinyurl.com/qfd4vut (accessed 27 January 2017) 
Department of Health (2013) Long term health conditions. DH, London. http://tinyurl.com/chfg3uq 
(accessed 30 January 2017) 
Eaton T, Rudkin S, Garrett JE (2001) The clinical utility of arterialized earlobe capillary blood in the 
assessment of patients for long-term oxygen therapy. Respir Med 95(8): 655–60. 
https://dx.doi.org/10.1053/rmed.2001.1118 
Fernandez S, Rodriguez O, Ortin JA et al (2013) Hospital at Home for acute exacerbations of chronic 
obstructive pulmonary disease (COPD). A series of 374 patients. Euro J Intern Med 24(1 suppl): e59-
60. http://tinyurl.com/ze8hp32 (accessed 27 January 2017) 
Guest JF (1999) The annual cost of chronic obstructive pulmonary disease to the UK’s National 
health Service. Dis Manage Health Outcomes 5(2):93-100. http://tinyurl.com/h6txe6f 
Rabe KF, Hurd S, Anzueto A et al (2016) Global strategy for the diagnosis, management, and 
prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit 
Care Med 176(6): 532-5. https://dx.doi.org/10.1164/rccm.200703-456SO (AQ: Ok to use this 
reference?) 
Jeppesen E, Brurberg KG, Vist GE et al (2012) Hospital at home for acute exacerbations of chronic 
obstructive pulmonary disease. Cochrane Database Syst Rev 5: CD003573. 
https://dx.doi.org/10.1002/14651858.CD003573.pub2 
Jones PW, Harding G, Berry P, Wiklund I, Chen W-H, Kline Leidy N. Development and first validation 
of the COPD Assessment Test. Eur Respir J 34(3): 648-54. 
https://dx.doi.org/10.1183/09031936.00102509 
Knolle MD, Challis B, Pearce L, Laroche C, Pulimood T (2011) Admission avoidance by hospital at 
home for exacerbations of COPD by a nurse-led team in the east of England. American Journal of 
Respiratory and Critical Care Medicine 183(1): 1073-449 
 16 
National Institute for Health and Care Excellence (2010) Chronic obstructive pulmonary disease in 
over 16s: diagnosis and management. Clinical guideline 101. NICE, London. 
http://tinyurl.com/grj6yny (accessed 30 January 2016) 
O’Reilly JF, Williams AE, Rice L (2007) Health status impairment and costs associated with COPD 
exacerbations managed in hospital. Int J Clin Pract 61(7): 1112-20. 
https://dx.doi.org/10.1111/j.1742-1241.2007.01424.x 
Pitkin AD, Roberts CM, Wedzicha JA (1994) Arterialised earlobe blood gas analysis: an underused 
technique. Thorax 49(4): 364-6 
Public Health England (2015) Protecting and Improving the nation’s health: Lincolnshire county 
Health Profile 2015. 
http://fingertips.phe.org.uk/profile/inhale/data#page/1/gid/8000003/pat/10011/par/cat-11-
4/ati/19/are/E38000100 (accessed 4th March, 2016) 
Puhan MA, Gimeno-Santos E, Cates CJ, Troosters T (2016) Pulmonary rehabilitation following 
exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev 12: CD005305. 
https://dx.doi.org/10.1002/14651858.CD005305.pub4 
Ram FSF, Wedzicha JA, Wright J, Greenstone M (2004) Hospital at home for patients with acute 
exacerbations of chronic obstructive pulmonary disease: systematic review of evidence. BMJ 
329(7461): 315. https://dx.doi.org/10.1136/bmj.38159.650347.55 
Royal College of Nursing (2010) Specialist Nurses: Changing Lives, Saving Money. Royal College of 
Nursing, London. http://tinyurl.com/judnmhr (accessed 27 January 2017) 
Shepperd S, Doll H, Angus RM et al (2008) Hospital at home admission avoidance. Cochrane 
Database Syst Rev 4: CD007491 https://dx.doi.org/ 10.1002/14651858.CD007491 
Shepperd S, Iliffe, S Doll H et al (2016) Admission avoidance hospital at home. Cochrane Database 
Syst Rev 9: CD007491. https://dx.doi.org/10.1002/14651858.CD007491.pub2 
Tashkin DP, Celli B, Senn S et al (2008) A 4-year trial of tiotropium In chronic obstructive pulmonary 
disease. New Engl J Med 359(15): 1543-54. https://dx.doi.org/10.1056/NEJMoa0805800 
Wilson PM, Kendall S, Brooks F (2006) Nurses’ responses to expert patients: the rhetoric and reality 




Table 1. Summary of actual costs of treatment specialist vs generalist care 
 Specialist Generalist 
Admissions of patients requiring 02 
assessment if under generalist care (n=2 
specialist vs 21 generalist) 
£5,268 £55,314 
Cost of visits for above £1,470 x 
Cost of emergency 02 for above £1,161.72 x 
Cost of other respiratory admissions (n=4) £10,536 £10,536 
Cost of other all cause admissions (n=4) £10,536 £10,536 
Total £28,971.72 £76,386 


















Age 74.4 ±11.1 68.8 ±9.8 72.6 ±9.2 
Sp02 93 ±3 93 ±3 94 ±3 
Nebulised therapy 82 (69.5%) 6 (100%) 10 (100%) 
Postive sputum result 12 (10%) 1 (16.6%) 1 (10%) 
Already receiving long term 
oxygen therapy 
48 (41%) 4 (66.6%) 6 (60%) 
CBG indicated (Sp02 ≤90%) 19 (16%) 2 (33.3%) 2 (20%) 
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Box 1. Comments from the patient satisfaction survey 
“Always very nice and explained things and seen to get things done” 
“So nice knowing someone was there to help with breathing and to give advice on how 
best to help me. Nothing could be improved the nurse was excellent and very helpful” 
“All care from this department is great” 
“The care I got from nurse coming in to my home kept me out of hospital. They are 
very caring and friendly people, highly recommended.” 
“The fact that honesty prevailed and I was involved and fully informed, on use of 




Figure 1. Source of referrals to ARAS 
 
Figure 2. Reasons for admissions 
